Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00708994
What this trial is testing

Cannabinoids, Neural Synchrony, and Information Processing

Who this might be right for
CannabisPsychotic Disorders
Yale University 42
Not applicableLooking for participantsNCT07056894
What this trial is testing

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

Who this might be right for
PsychosisAlcohol Use DisorderCannabis Use Disorder
Nova Scotia Health Authority 50
Not applicableStudy completedNCT06791122
What this trial is testing

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 262
Not applicableStudy completedNCT05127837
What this trial is testing

CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

Who this might be right for
PsychosisSchizophreniaSchizo Affective Disorder+2 more
University of Washington 601
Not applicableNot Yet RecruitingNCT07108673
What this trial is testing

Value of Voxel-Based Morphometry in Schizophrenia

Who this might be right for
Schizophrenia
Assiut University 96
Testing effectiveness (Phase 2)WithdrawnNCT01905605
What this trial is testing

Phosphatidylcholine Supplementation in Infants

Who this might be right for
SchizophreniaDiminished P50 Sensory Gating
University of Colorado, Denver
Not applicableStudy completedNCT00538629
What this trial is testing

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Who this might be right for
Bipolar DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 471
Not applicableUnknownNCT01357005
What this trial is testing

Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan

Who this might be right for
Schizophrenia
Far Eastern Memorial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00770744
What this trial is testing

Efficacy of Lu 31-130 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 93
Not applicableStudy completedNCT03286595
What this trial is testing

Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings

Who this might be right for
PsychosisClinical High Risk for Psychosis
University of California, Davis 60
Not applicableWithdrawnNCT03758495
What this trial is testing

Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression

Who this might be right for
SchizophreniaDepressive Disorder, Major
VA Office of Research and Development
Large-scale testing (Phase 3)Study completedNCT00249119
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder
Janssen, LP 1,579
Not applicableStudy completedNCT02498236
What this trial is testing

Target Engagement for Oxytocin: Dose Ranging Study

Who this might be right for
Schizophrenia Spectrum
University of California, Los Angeles 51
Not applicableStudy completedNCT07437365
What this trial is testing

Theta- and Alpha-Tuned Meditation for Negative Symptoms in Schizophrenia

Who this might be right for
Schizophenia Disorder
Psychiatric Hospital of the Cross 90
Large-scale testing (Phase 3)Study completedNCT00366171
What this trial is testing

Open Label Extension Study of Bifeprunox

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 120
Not applicableStudy completedNCT02101372
What this trial is testing

Intervention Module AGES

Who this might be right for
Psychosis
Celso Arango 55
Early research (Phase 1)Study completedNCT02824666
What this trial is testing

Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242

Who this might be right for
Schizophrenia
Braeburn Pharmaceuticals 7
Early research (Phase 1)Study completedNCT00611741
What this trial is testing

The Effect of Plasma Osmolality on Brain Glutamate

Who this might be right for
Schizophrenia
Yale University 30
Large-scale testing (Phase 3)Study completedNCT02054702
What this trial is testing

Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 97
Not applicableStudy completedNCT00179231
What this trial is testing

Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Vanderbilt University 80
Next Page